##  [Novartis and Amgen announce FDA approval of Aimovig™ (erenumab-aooe), a novel treatment developed specifically for migraine prevention](/us-en/news/media-releases/novartis-and-amgen-announce-fda-approval-aimovigtm-erenumab-aooe-novel-treatment-developed-specifically-migraine-prevention-0 "Novartis and Amgen announce FDA approval of Aimovig™ (erenumab-aooe), a novel treatment developed specifically for migraine prevention") 

  May 17, 2018